Option chain shows key data for Lionsgate Studios's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Lionsgate Studios.

Lionsgate Studios (NASDAQ:LION) Stock, Option Chain

Lionsgate Studios

Fidelity Southern Corporation - Common Stock

Fidelity Southern

Fidelity Southern Corporation

Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.

xr:d:DAFeeIkW91A:2,j:1670940971,t:23032808

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ACLX

APLS

FRPT

LION

LULU

NXPI

Lululemon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday

Upgrades

ARGX

CRWD

LUMN

This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Kai Cenat

Entertainment

Gaming

AMZN

A real-life version of &#34;The Hunger Games&#34; could pit 50 content creators against each other.

&#39;Hunger Games&#39; In Real Life? Content Creator Planning &#39;First Fully Professionally Organized Live&#39; Version Of Popular Book And Movie Franchise

Lionsgate Studios Corp

LION COPPER & GOLD CORP by LION COPPER & GOLD CORP.

Lion Copper and Gold Corp

Lion Corp

Lion Energy Ltd

Lion Group Holding Ltd. - American Depositary Share

Lion Group Holding Ltd

LION ONE METALS LTD by Lion One Metals Ltd.

Lion One Metals Ltd

LION ROCK RESOURCES INC by Lion Rock Resources Inc.

Lion Rock Resources Inc

Lion Rock Resources Inc A

Lionheart Holdings - Class A Ordinary Shares

Lionheart Holdings

Lions Gate Entertainment Corporation Class A Voting Shares

Lions Gate Entertainment Corp

Lions Gate Entertainment Corporation Class B Non-Voting Shares

LIONTOWN RESOURCES LTD by Liontown Resources Ltd.

Liontown Resources Ltd

LIONSGATE'S "THE BEST CHRISTMAS PAGEANT EVER" CLOSES OUT KINGDOM'S BIGGEST SLATE YET
BRANDON GREGORY NAMED PARTNER
SANTA MONICA, Calif., Nov. 13, 2024 /PRNewswire/ -- Lionsgate and Kingdom Story Company announced today that the companies have agreed to renew their three-year first-look deal, extending the studios' total collaboration to ten years. The announcement was made by Adam Fogelson, chair, Lionsgate Motion Picture Group, and Kevin Downes, CEO, Kingdom Story Company.
The new deal puts a capstone on Kingdom Story Company's biggest slate yet as the companies collaborated on three films in 2024:&nbsp;Ordinary Angels, starring Hilary Swank and Alan Ritchson;&nbsp;Unsung&nbsp;Hero, the autobiographical film from five-time Grammy Award-winning artist Joel Smallbone, whose band for KING + COUNTRY is one of the most decorated and respected bands for faithful audiences; and&nbsp;The Best Christmas Pageant Ever, directed by Dallas Jenkins ("The Chosen"), an adaptation of the beloved classic children's book.&nbsp;The Best Christmas Pageant Ever exceeded tracking and industry expectations by opening with a strong $10.8 million at the domestic box office this past weekend ($12.2 M/4-day) and is positioned to continue playing through the holiday period.&nbsp; Each of the Kingdom developed and produced films released in 2024 is expected to be profitable for the studio.
The company also announced that it has promoted Brandon Gregory, Kingdom Story Company's president and COO, to partner.

Lionsgate And Kingdom Story Company Announced Today That The Companies Have Agreed To Renew Their 3-Year First-Look Deal, Extending The Studios' Total Collaboration To 10 Years

Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.06) by 550 percent. This is a 750 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $823.70 million which beat the analyst consensus estimate of $748.00 million by 10.12 percent.

Earnings

Earnings Beats

Earnings Misses

Lionsgate Studios Q2 2025 GAAP EPS $(0.39) Misses $(0.06) Estimate, Sales $823.70M Beat $748.00M Estimate

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Needham cut Apellis Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) price target from $85 to $60. Needham analyst Joseph Stringer maintained a Buy rating. Apellis Pharmaceuticals shares closed at $28.08 on Tuesday. See how other analysts view this stock.</li>
<li>Deutsche Bank raised the price target for Emerson Electric Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) from $136 to $140. Deutsche Bank analyst Nicole Deblase maintained a Buy rating. Emerson Electric shares closed at $117.67 on Tuesday. <a href="https://www.benzinga.com/quote/EMR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co raised the price target for Arcellx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) from $80 to $95. HC Wainwright &amp; Co. analyst Emily Bodnar maintained a Buy rating. Arcellx shares closed at $87.12 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley slashed NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) price target from $250 to $235. Morgan Stanley analyst Joseph Moore maintained an Equal-Weight rating. NXP Semiconductors shares settled at $224.65 on Tuesday. <a href="https://www.benzinga.com/quote/NXPI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel raised Freshpet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) price target from $155 to $165. Stifel analyst Mark Astrachan maintained a Buy rating. Freshpet shares closed at $151.59 on Tuesday. <a href="https://www.benzinga.com/quote/FRPT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird increased Choice Hotels International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHH#NYSE">CHH</a>) price target from $138 to $145. Baird analyst Michael Bellisario maintained an Outperform rating. Choice Hotels shares closed at $139.46 on Tuesday. <a href="https://www.benzinga.com/quote/CHH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird raised the price target for Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) from $350 to $380. Baird analyst Mark Altschwager maintained an Outperform rating. Lululemon shares settled at $319.23 on Tuesday. <a href="https://www.benzinga.com/quote/LULU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley raised Broadridge Financial Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BR#NYSE">BR</a>) price target from $200 to $207. Morgan Stanley analyst James Faucette maintained an Equal-Weight rating. Broadridge Financial shares closed at $218.30 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird boosted the price target for Cummins Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NASDAQ">CMI</a>) from $330 to $372. Baird analyst David Leiker maintained a Neutral rating. Cummins shares closed at $354.46 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut Lionsgate Studios Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) price target from $133 to $173. Truist Securities analyst Jamie Cook upgraded the stock from Hold to Buy. Lionsgate Studios shares closed at $6.76 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41744659/jim-cramer-says-he-cant-recommend-this-major-automaker-ceva-is-way-too-high">Jim Cramer Says He Can&#8217;t Recommend This Major Automaker, Ceva Is &#8216;Way Too High&#8217;</a></li>
</ul>

Morgan Stanley analyst Thomas Yeh maintains Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) with a Overweight and lowers the price target from $9 to $8.

Morgan Stanley Maintains Overweight on Lionsgate Studios, Lowers Price Target to $8

Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.06) by 166.67 percent. The company reported quarterly sales of $588.400 million which missed the analyst consensus estimate of $645.300 million by 8.82 percent.

Lionsgate Studios Q1 2025 GAAP EPS $(0.16) Misses $(0.06) Estimate, Sales $588.400M Miss $645.300M Estimate

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our<a href="https://www.benzinga.com/analyst-stock-ratings"> analyst ratings page.</a>
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/590783e6290fa70001409b4a/rob-owens">Piper Sandler analyst Rob Owens</a> upgraded the rating for CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) from Neutral to Overweight, but lowered the price target from $310 to $290. CrowdStrike shares gained 1.9% to close at $222.05 on Monday. <a href="https://www.benzinga.com/quote/CRWD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Seaport Global analyst David Joyce upgraded Lionsgate Studios Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) from Neutral to Buy and announced a price target of $12. Lionsgate Studios shares gained 1% to close at $7.12 on Monday. <a href="https://www.benzinga.com/quote/LION/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586bc4bd351b9b0001ab7363/michael-rollins">Citigroup analyst Michael Rollins</a> upgraded the rating for Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) from Sell to Neutral and raised the price target from $1.25 to $3.15. Lumen Technologies shares fell 15.6% to close at $2.59 on Monday. <a href="https://www.benzinga.com/quote/LUMN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan analyst Rajat Gupta upgraded Sonic Automotive, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>) from Neutral to Overweight, while boosting the price target from $58 to $63. Sonic Automotive shares gained 3.4% to close at $57.78 on Monday. <a href="https://www.benzinga.com/quote/SAH/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays analyst Charles Pitman upgraded the rating for argenx SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) from Equal-Weight to Overweight. argenx shares fell 3% to close at $484.52 on Monday. See how other analysts view this stock. <a href="https://www.benzinga.com/quote/ARGX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40178833/dow-records-worst-day-in-around-2-years-mag-7-stocks-lose-650b-in-market-capitalization-greed-index">Dow Records Worst Day In Around 2 Years, Mag 7 Stocks Lose $650B In Market Capitalization: Greed Index Moves To &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>

Seaport Global analyst David Joyce upgrades Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) from Neutral to Buy and announces $12 price target.

Seaport Global Upgrades Lionsgate Studios to Buy, Announces $12 Price Target

Morgan Stanley analyst Thomas Yeh initiates coverage on Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) with a Overweight rating and announces Price Target of $9.5.

Initiation

Morgan Stanley Initiates Coverage On Lionsgate Studios with Overweight Rating, Announces Price Target of $9.5

Seaport Global initiates coverage on Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) with a Neutral rating.

Seaport Global Initiates Coverage On Lionsgate Studios with Neutral Rating

Citigroup analyst Jason Bazinet initiates coverage on Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) with a Buy rating and announces Price Target of $14.

Citigroup Initiates Coverage On Lionsgate Studios with Buy Rating, Announces Price Target of $14

<h3>Gainers</h3>
<ul>
<li>Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>) shares moved upwards by 12.1% to $9.07 during Friday's pre-market session. The market value of their outstanding shares is at $2.6 billion. </li>
<li>Starbox Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) stock increased by 10.52% to $0.21. The company's market cap stands at $31.3 million. </li>
<li>Leafly Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFLY#NASDAQ">LFLY</a>) shares increased by 7.49% to $1.72. The market value of their outstanding shares is at $4.0 million. </li>
<li>Phoenix New Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENG#NYSE">FENG</a>) stock rose 7.2% to $2.68. The market value of their outstanding shares is at $32.1 million. </li>
<li>GD Culture Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>) shares moved upwards by 7.13% to $0.9. The company's market cap stands at $7.1 million. </li>
<li>Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) stock rose 6.59% to $0.53. The market value of their outstanding shares is at $7.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sify Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) shares declined by 38.1% to $1.04 during Friday's pre-market session. The market value of their outstanding shares is at $190.6 million. </li>
<li>Hanryu Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRYU#NASDAQ">HRYU</a>) stock fell 12.11% to $0.33. The market value of their outstanding shares is at $17.4 million. </li>
<li>VS Media Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) stock decreased by 5.97% to $0.32. The company's market cap stands at $7.0 million. </li>
<li>Fangdd Network Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUO#NASDAQ">DUO</a>) shares declined by 5.69% to $0.78. The market value of their outstanding shares is at $5.0 million. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) stock fell 5.53% to $0.47. The company's market cap stands at $4.7 million. </li>
<li>Intelligent Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTJ#NASDAQ">INTJ</a>) shares decreased by 4.77% to $1.0. The market value of their outstanding shares is at $13.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ASST

FENG

HRYU

INTJ

LFLY

MITQ

SIFY

STBX

VSME

12 Communication Services Stocks Moving In Friday's Pre-Market Session

Content creator Kai Cenat is quickly becoming one of the most well-known streamers — and <a href="https://www.benzinga.com/news/23/03/31113988/from-noob-to-pro-meet-the-twitch-streamer-who-just-hit-300k-subscribers">the most subscribed person on Twitch.</a>
Cenat has been developing a new stunt that could become one of the most highly anticipated events from a content creator.
Related Link: <a href="https://www.benzinga.com/general/entertainment/23/08/33585952/benzinga-buzz-who-is-kai-cenat-plus-paul-reubens-t-swift-ye-dungeons-dragons-bears-it-all">Benzinga Buzz: Who Is Kai Cenat? Plus: Paul Reubens, T-Swift, Ye, Dungeons &amp; Dragons &#8216;Bears&#8217; It All</a>
 What Happened: Cenat's popularity has grown in recent years,<a href="https://www.benzinga.com/news/earnings/23/05/32407611/rumble-q1-earnings-report-video-platform-adds-kai-cenat-ishowspeed-david-sacks-joins-board-revenue-"> even landing him a deal</a> with Rumble Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUM#NASDAQ">RUM</a>).
The streamer recently revealed that he has a project planned for 50 content creators to participate in a live version of the popular book and movie franchise &#8220;The Hunger Games.&#8221;
Cenat announced the plans during a stream and said he has been working on the event for six months, <a href="https://www.dexerto.com/entertainment/kai-cenat-planning-live-hunger-games-style-event-with-50-popular-influencers-2737327/">Dexerto</a> reported.
The popular content creator said he would be "hosting the very first fully professionally organized live &#8216;Hunger Games.&#8217;"
Why It's Important: The event may sound familiar to those who follow MrBeast, who did a real-life version of the hit Netflix series "Squid Games."
That video from MrBeast is his most-watched episode to date, with 612 million views since its release in November 2021.
In "The Hunger Games," residents of different districts fight to the death until one remains as victor. Lionsgate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGF#NYSE">LGF</a>)(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGF#NYSE">LGF</a>), which recently <a href="https://www.benzinga.com/m-a/23/12/36361384/lionsgate-forms-4-6b-studio-giant-with-screaming-eagle-spac-merger">spun off its studio division</a> as Lionsgate Studios (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LION#NASDAQ">LION</a>), turned the book series into a massively successful film series. 
One of the big questions will be where Cenat will stream the &#8220;Hunger Games&#8221;-style event. The content creator has 10.6 million followers on Twitch, a deal with Rumble, and 5.6 million followers on YouTube.
Given his wide reach on Twitch, the platform could make the most sense. Twitch is owned by Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), which <a href="https://www.benzinga.com/general/entertainment/24/03/37809533/mrbeast-confirms-beast-games-on-amazon-prime-video-with-1-000-contestants-5m-prize-its-gonn">recently signed MrBeast</a> to a deal for a game show on its Prime Video streaming platform.
Read Next: <a href="https://www.benzinga.com/news/21/11/24369935/mr-beasts-squid-game-video-has-more-views-in-a-week-than-netflixs-show-had-in-first-month">Mr. Beast&#8217;s &#8216;Squid Game&#8217; Video Has More Views In A Week Than Netflix&#8217;s Show Had In First Month</a>
Photo: Shutterstock

'Hunger Games' In Real Life? Content Creator Planning 'First Fully Professionally Organized Live' Version Of Popular Book And Movie Franchise

WIIM

Lionsgate Studios shares are trading lower after the company reported Q4 financial results.

Lionsgate Studios Q4 2024 Adj. EPS $0.27 Up From $0.21 YoY; Revenue $1.117B Up From $1.085B YoY

<h3>Gainers</h3>
<ul>
<li>Exela Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xela#NASDAQ">XELA</a>) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions.</li>
<li>BioRestorative Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brtx#NASDAQ">BRTX</a>) shares jumped 34.7% to $3.76 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company&#39;s metabolic ThermoStem program.</li>
<li>Diversified Healthcare Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dhc#NASDAQ">DHC</a>) surged 30% to $1.21 after the company posted a profit for the fourth quarter.</li>
<li>Desktop Metal, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dm#NYSE">DM</a>) gained 23% to $1.8550 after the company reported better-than-expected Q4 sales results and issued guidance.</li>
<li>OncoSec Medical Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oncs#NASDAQ">ONCS</a>) gained 22.7% to $2.52. OncoSec Medical shares jumped around 89% on Wednesday after the company requested the withdrawal of its registration statement, saying it has opted not to pursue the offering at this time.</li>
<li>Frontdoor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftdr#NASDAQ">FTDR</a>) shares climbed 16.8% to $32.67 after the company posted Q4 results.</li>
<li>China Jo-Jo Drugstores, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cjjd#NASDAQ">CJJD</a>) gained 16% to $4.55.</li>
<li>FOXO Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/foxo#NASDAQ">FOXO</a>) gained 16% to $0.6128.</li>
<li>Advantage Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adv#NASDAQ">ADV</a>) gained 15.9% to $2.5850 following strong quarterly sales.</li>
<li>Macy&#39;s, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/m#NYSE">M</a>) gained 13.3% to $23.15 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued guidance.</li>
<li>Okta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okta#NASDAQ">OKTA</a>) shares rose 13.2% to $80.84 after the company reported better-than-expected Q4 results and issued strong guidance.</li>
<li>Stagwell Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stgw#NASDAQ">STGW</a>) gained 12% to $7.61 following upbeat quarterly results.</li>
<li>Salesforce, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crm#NYSE">CRM</a>) rose 11.5% to $186.64 after the company reported better-than-expected Q4 results and issued strong guidance.</li>
<li>Bright Health Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhg#NASDAQ">BHG</a>) shares rose 11.1% to $0.56. Bright Health Group shares dropped 42% on Wednesday after the company reported Q4 financial results..</li>
<li>CRH plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crh#NYSE">CRH</a>) rose 8.2% to $51.35. Redburn Partners recently upgraded the stock from Neutral to Buy.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) gained 7.6% to $1.7007 after jumping 37% on Wednesday. On February 22, MMTec raised $32 million by issuing an unsecured senior convertible promissory note worth $40 million to a non-U.S. investor under a securities purchase deal.</li>
<li>POET Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/poet#NASDAQ">POET</a>) surged 7.5% to $4.58. POET Technologies recently announced a strategic collaboration with ADVA Optical Networking for the use of POET&#39;s multi-engine 100G CWDM4 and 100G LR4 chip-on-board solutions.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) rose 7.1% to $7.07 after jumping 91% on Wednesday. Cardio Diagnostics announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Silvergate Capital Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/si#NYSE">SI</a>) dropped 42.6% to $7.75 after the company delayed the filing of its Form 10-K with the SEC.</li>
<li>ZimVie Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zimv#NASDAQ">ZIMV</a>) shares dipped 40.6% to $6.22 after the company reported worse-than-expected Q4 adjusted EPS and sales results and issued FY23 adjusted EPS and net sales guidance below estimates.</li>
<li>HPX Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hpx#NYSE">HPX</a>) fell 28% to $19.49 after shareholders approved the proposed business combination with Emergencia Participacoes.</li>
<li>Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) fell 26.8% to $3.8950 after the company posted downbeat Q4 sales and issued weak sales forecast for the first quarter.</li>
<li>Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) shares fell 22.9% to $1.21 after the company reported worse-than-expected Q4 earnings and issued weak FY23 revenue guidance.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) fell 22.4% to $27.93 after gaining around 8% on Wednesday.</li>
<li>Lottery.com Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltry#NASDAQ">LTRY</a>) dropped 21.8% to $0.4667.</li>
<li>Lucira Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lhdx#NASDAQ">LHDX</a>) fell 21% to $0.6217.</li>
<li>Tuya Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tuya#NYSE">TUYA</a>) dipped 20% to $1.49 following Q4 results.</li>
<li>Funko, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fnko#NASDAQ">FNKO</a>) fell 16.2% to $9.04 after the company reported worse-than-expected Q4 EPS and issued weak Q1 guidance.</li>
<li>Secoo Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seco#NASDAQ">SECO</a>) declined 15.7% to $1.50.</li>
<li>Pure Storage, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pstg#NYSE">PSTG</a>) fell 15% to $24.43 after the company reported mixed Q4 financial results and issued guidance.</li>
<li>Cyren Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyrn#NASDAQ">CYRN</a>) dipped 14.7% to $0.2344. CYREN recently announced it will be delisted from the Nasdaq.</li>
<li>Snowflake Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snow#NYSE">SNOW</a>) shares fell 14.7% to $131.77 after the data company reported fourth-quarter financial results.</li>
<li>The Aaron&#39;s Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aan#NYSE">AAN</a>) fell 14.4% to $12.33 following Q4 results.</li>
<li>Funko, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fnko#NASDAQ">FNKO</a>) dropped 14.3% to $9.17 after the company reported worse-than-expected Q4 EPS and issued weak Q1 guidance.</li>
<li>MP Materials Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mp#NYSE">MP</a>) fell 13.6% to $30.95 after Tesla said it has designed a permanent magnet motor, which does not use rare earth minerals.</li>
<li>Box, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/box#NYSE">BOX</a>) fell 12.9% to $29.24 after the company issued weak Q1 and FY24 guidance.</li>
<li>Zai Lab Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zlab#NASDAQ">ZLAB</a>) dropped 12.8% to $35.19. Zai Lab posted a FY22 loss of $0.46 per share.</li>
<li>Wolfspeed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wolf#NYSE">WOLF</a>) shares dropped 11.4% to $66.31.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) fell 10.2% to $3.70.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) fell 9.9% to $58.23. Coinbase stopped accepting payments to or from Silvergate Capital.</li>
<li>Lionheart III Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lion#NASDAQ">LION</a>) fell 9.6% to $10.63 after dropping around 20% on Wednesday.</li>
<li>Principal Financial Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfg#NYSE">PFG</a>) dropped 8.2% to $83.75.</li>
<li>ON Semiconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/on#NASDAQ">ON</a>) fell 6.2% to $73.35 after Raymond James downgraded the stock from Outperform to Market Perform. ON Semiconductor recently raised $1.3 billion via an upsized institutional offering of 0.50% convertible senior notes due 2029.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/03/31170869/ethereum-falls-but-remains-above-this-key-level-immutablex-becomes-top-loser"> Ethereum Falls But Remains Above This Key Level; ImmutableX Becomes Top Loser </a>

Penny Stocks

Small Cap

Intraday Update

AEHR

BRTX

CANO

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CDLX

CJJD

CMAX

COIN

CYRN

FNKO

FOXO

FTDR

LHDX

LTRY

OKTA

ONCS

POET

PSTG

SECO

SNOW

STGW

TUYA

WOLF

XELA

ZIMV

ZLAB

Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) rose 76% to $2.78 in pre-market trading after jumping 37% on Wednesday. On February 22, MMTec raised $32 million by issuing an unsecured senior convertible promissory note worth $40 million to a non-U.S. investor under a securities purchase deal.</li>
<li>Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) rose 71.7% to $0.28 in pre-market trading. Blue Star Foods recently priced a $1.8 million underwritten public offering of common stock.</li>
<li>Lucira Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lhdx#NASDAQ">LHDX</a>) rose 15.2% to $0.91 in pre-market trading after dropping 15% on Wednesday. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 &amp; flu test.</li>
<li>Salesforce, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crm#NYSE">CRM</a>) rose 14.7% to $192.00 in pre-market trading after the company reported better-than-expected Q4 results and issued strong guidance.</li>
<li>Okta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okta#NASDAQ">OKTA</a>) shares rose 14.1% to $81.51 in pre-market trading after the company reported better-than-expected Q4 results and issued strong guidance.</li>
<li>HPX Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hpx#NYSE">HPX</a>) rose 13.8% to $30.80 in pre-market trading after shareholders approved the proposed business combination with Emergencia Participacoes.</li>
<li>OncoSec Medical Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oncs#NASDAQ">ONCS</a>) shares rose 12.2% to $2.29 in pre-market trading. OncoSec Medical shares jumped around 89% on Wednesday after the company requested the withdrawal of its registration statement, saying it has opted not to pursue the offering at this time.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) rose 12.1% to $7.40 in pre-market trading after jumping 91% on Wednesday. Cardio Diagnostics announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.</li>
<li>Bright Health Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhg#NASDAQ">BHG</a>) shares rose 11.1% to $0.56 in pre-market trading. Bright Health Group shares dropped 42% on Wednesday after the company reported Q4 financial results..</li>
<li>CRH plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crh#NYSE">CRH</a>) rose 11.1% to $52.74 in pre-market trading. Redburn Partners recently upgraded the stock from Neutral to Buy.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Silvergate Capital Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/si#NYSE">SI</a>) fell 30% to $9.47 in pre-market after the company said it is unable to file its Form 10-K for 2022 with the SEC.</li>
<li>Funko, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fnko#NASDAQ">FNKO</a>) fell 25.2% to $8.00 in pre-market trading after the company reported worse-than-expected Q4 EPS and issued weak Q1 guidance.</li>
<li>Lionheart III Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lion#NASDAQ">LION</a>) fell 21.6% to $9.20 in pre-market trading after dropping around 20% on Wednesday.</li>
<li>Cano Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cano#NYSE">CANO</a>) shares fell 15.3% to $1.33 in pre-market trading after the company reported worse-than-expected Q4 earnings and issued weak FY23 revenue guidance.</li>
<li>Wolfspeed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wolf#NYSE">WOLF</a>) shares dropped 9.9% to $67.43 in pre-market trading.</li>
<li>Aehr Test Systems (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehr#NASDAQ">AEHR</a>) fell 9.7% to $32.50 in pre-market trading after gaining around 8% on Wednesday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) fell 8.1% to $1.94 in pre-market trading after gaining over 3% on Wednesday.</li>
<li>ON Semiconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/on#NASDAQ">ON</a>) fell 7.8% to $72.16 in pre-market trading. ON Semiconductor recently raised $1.3 billion via an upsized institutional offering of 0.50% convertible senior notes due 2029..</li>
<li>Snowflake Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snow#NYSE">SNOW</a>) shares fell 7.2% to $143.42 in pre-market trading after the data company reported fourth-quarter financial results.</li>
<li>Tesla, Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) fell 5.2% to $192.30 in pre-market trading. Tesla held its first Investor Day event on Wednesday, where the company&rsquo;s CEO Elon Musk unveiled the third part of his Master Plan.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/23/03/31123175/check-out-3-high-yielding-dividend-stocks-in-real-estate-sector-from-wall-streets-most-accurate-anal"> Check Out 3 High-Yielding Dividend Stocks In Real Estate Sector From Wall Street&#39;s Most Accurate Analysts</a>

BSFC

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

TSLA

Why Salesforce Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Reata Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reta#NASDAQ">RETA</a>) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich&#39;s Ataxia.</li>
<li>OncoSec Medical Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oncs#NASDAQ">ONCS</a>) rose 75.9% to $1.90 in pre-market trading after the company requests withdrawal of registration statement, The company said it has opted not to pursue offering thereby at this time.</li>
<li>Lionheart III Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lion#NASDAQ">LION</a>) shares rose 56.2% to $22.80 in pre-market trading after jumping around 98% on Tuesday.</li>
<li>China Pharma Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cphi#NASDAQ">CPHI</a>) rose 20.8% to $0.081 in pre-market trading. China Pharma recently announced a 1-for-10 reverse stock split.</li>
<li>Helbiz Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlbz#NASDAQ">HLBZ</a>) rose 19.1% to $0.17 in pre-market trading after gaining over 21% on Tuesday.</li>
<li>Sarepta Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srpt#NASDAQ">SRPT</a>) rose 17% to $142.90 in pre-market trading after the company reported better-than-expected Q4 results.</li>
<li>Landos Biopharma Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/labp#NASDAQ">LABP</a>) shares rose 14.9% to $0.43 in pre-market trading. Landos Biopharma announced transfer of LANCL portfolio, including Omilancor, LABP-104 and LABP-111 to Landos&#39; founder.</li>
<li>China SXT Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtc#NASDAQ">SXTC</a>) rose 14.7% to $0.45 in pre-market trading after gaining over 3% on Tuesday.</li>
<li>Cerevel Therapeutics Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cere#NASDAQ">CERE</a>) rose 9.7% to $29.30 in pre-market trading. Cerevel Therapeutics recently posted a narrower-than-expected quarterly loss.</li>
<li>Bilibili Inc - ADR (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) shares rose 8.8% to $21.00 in pre-market trading after dropping over 3% on Tuesday.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>OKYO Pharma (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okyo#NASDAQ">OKYO</a>) fell 24.2% to $1.69 in pre-market. US Customs cleared OKYO Pharma&#39;s GMP packaged OK-101 drug for Phase 2 clinical trial for treating dry eye disease.</li>
<li>Novavax Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) fell 24% to $7.04 in pre-market trading after the company reported worse-than-expected Q4 results and said substantial doubt exists regarding its ability to continue as a going concern.</li>
<li>Marqeta Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mq#NASDAQ">MQ</a>) fell 19.1% to $4.69 in pre-market trading after the company reported fourth-quarter results and issued guidance for slowing growth.</li>
<li>Beamr Imaging Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmr#NASDAQ">BMR</a>) shares fell 18.6% to $2.97 in pre-market trading. Beamr Imaging priced its initial public offering of 1,950,000 at a public offering price of $4.00 per share.</li>
<li>Obseva SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/obsv#NASDAQ">OBSV</a>) shares dropped 15.2% to $0.12 in pre-market trading after jumping 43% on Tuesday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.</li>
<li>Brightspire Capital Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brsp#NYSE">BRSP</a>) fell 14.4% to $6.32 in pre-market trading after the company announced an offering of 30,358,213 shares by DigitalBridge Group, Inc.</li>
<li>Performance Shipping Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pshg#NASDAQ">PSHG</a>) fell 13% to $2.34 in pre-market trading. Performance Shipping announced termination of at-the-market offering.</li>
<li>Grove Collaborative Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grov#NYSE">GROV</a>) fell 12.7% to $0.38 in pre-market trading.</li>
<li>Catalyst Biosciences Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbio#NASDAQ">CBIO</a>) fell 11.4% to $0.26 in pre-market trading. Catalyst Biosciences shares jumped around 24% on Tuesday after GC Biopharma signed an Asset Purchase Agreement with the company.</li>
<li>AMC Entertainment Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) shares fell 8.5% to $6.53 in pre-market trading after the company posted Q4 results. The company ended the quarter with available liquidity of $842.7 million and debt of $4.95 billion.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/23/02/31090297/top-5-health-care-stocks-that-you-may-want-to-dump-in-q1-2023"> Top 5 Health Care Stocks That You May Want To Dump In Q1 2023</a>

BILI

BRSP

CBIO

CERE

CPHI

GROV

HLBZ

LABP

NVAX

OBSV

OKYO

PSHG

RETA

SRPT

SXTC

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Versus Systems Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vs#NASDAQ">VS</a>) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit management.</li>
<li>EBET, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ebet#NASDAQ">EBET</a>) gained 108% to $1.97</li>
<li>Motorsport Games Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msgm#NASDAQ">MSGM</a>) shares jumped 92.3% to $41.15. Motorsport Games agreed to raise $3.9 million at par via private placement of shares for developing multiple games, working capital and general corporate purposes.</li>
<li>Bright Green Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bgxx#NASDAQ">BGXX</a>) gained 91.3% to $0.9993. Bright Green announced plans to raise $500 million under EB-5 Capital Program.</li>
<li>Recruiter.com Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcrt#NASDAQ">RCRT</a>) rose 80.4% to $0.8520. Recruiter.com Group reported the launch of a comprehensive content series that explores the powerful impact of the artificial intelligence technology, ChatGPT, on talent acquisition and recruiting.</li>
<li>SharpLink Gaming Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbet#NASDAQ">SBET</a>) gained 50% to $0.81</li>
<li>Iveda Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivda#NASDAQ">IVDA</a>) jumped 47.2% to $1.39</li>
<li>Mobile Global Esports Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgam#NASDAQ">MGAM</a>) gained 36.1% to $3.51 after jumping 158% on Tuesday. Mobile Global Esports said Nicholas (Nick) Venezia has joined MOGO as Chief Data Officer.</li>
<li>Quoin Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) shares climbed 36% to $2.27 after gaining around 10% on Tuesday.</li>
<li>Impac Mortgage Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/imh#NYSE">IMH</a>) jumped 25% to $0.3350.</li>
<li>Chembio Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cemi#NASDAQ">CEMI</a>) rose 23.3% to $0.4401. Biosynex and Chembio Diagnostics reported a definitive acquisition agreement.</li>
<li>Rapid7, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rpd#NASDAQ">RPD</a>) gained 23.2% to $49.13. Rapid7 is working with Goldman Sachs Group to explore a potential sale, Reuters reported.</li>
<li>ERYTECH Pharma S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eryp#NASDAQ">ERYP</a>) jumped 22.2% to $1.10.</li>
<li>Engine Gaming and Media, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/game#NASDAQ">GAME</a>) gained 22.2% to $1.4673.</li>
<li>Pintec Technology Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pt#NASDAQ">PT</a>) jumped 22.2% to $0.4690.</li>
<li>Peloton Interactive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) gained 21% to $15.58 after the company reported better-than-expected Q2 sales results and issued guidance.</li>
<li>MicroVision, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvis#NASDAQ">MVIS</a>) gained 16.3% to $2.9187.</li>
<li>Mercury Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrcy#NASDAQ">MRCY</a>) jumped 16.2% to $58.08 following Q2 results.</li>
<li>Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) shares gained 14.9% to $12.40.</li>
<li>LivePerson, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpsn#NASDAQ">LPSN</a>) gained 14.3% to $14.72. LivePerson highlighted Conversational Cloud with Generative AI.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) rose 14.3% to $0.8578 after the company reported preclinical results with immunotherapy candidate TTX-RIGA in melanoma.</li>
<li>Baidu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bidu#NASDAQ">BIDU</a>) gained 13.3% to $152.55.</li>
<li>Lionheart III Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lion#NASDAQ">LION</a>) rose 12.2% to $11.68 after dropping over 10% on Tuesday.</li>
<li>TMC The Metals Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) rose 12.2% to $0.9804. TMC The Metals Company recently filed prospectus for offering of up to $30 million common shares.</li>
<li>Marin Software Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrin#NASDAQ">MRIN</a>) rose 9.1% to $1.32 after the company disclosed a new integration with Yahoo to enable enhanced campaign buying and optimization for advertisers.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Taysha Gene Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsha#NASDAQ">TSHA</a>) fell 34.2% to $1.0799 after the company issued an update on TSHA-120 program in giant axonal neuropathy and a 2023 corporate outlook.</li>
<li>Cyren Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyrn#NASDAQ">CYRN</a>) dropped 28% to $0.5366. Cyren announced global reduction in force by 121 employees representing substantially all of the company&#39;s workforce.</li>
<li>Evelo Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evlo#NASDAQ">EVLO</a>) dropped 22.8% to $0.8024. Evelo Biosciences said data from first three cohorts of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint.</li>
<li>SOBR Safe, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sobr#NASDAQ">SOBR</a>) fell 16.1% to $1.51. SOBR Safe shares jumped 62% on Tuesday after the company announced that its first two SOBRcheck installations in the oil and gas industry were successful, driving expansion across all US locations for TerraTech Services.</li>
<li>Varex Imaging Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrex#NASDAQ">VREX</a>) dropped 15% to $18.25 after the company issued Q2 EPS guidance below analyst estimates.</li>
<li>Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) fell 14.4% to $0.4450 after gaining more than 24% on Tuesday. Blue Star Foods entered into supply agreement with Just Food For Dogs for up to $4 million annually.</li>
<li>Hawaiian Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ha#NASDAQ">HA</a>) dropped 14.2% to $10.57 following downbeat Q4 sales.</li>
<li>G Medical Innovations Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmvd#NASDAQ">GMVD</a>) fell 13.9% to $4.2950 after declining around 8% on Tuesday. G Medical Innovations recently announced it received notice of patent issuance from the United States Patent and Trademark Office (USPTO) for vital signs sensors.</li>
<li>WestRock Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wrk#NYSE">WRK</a>) shares fell 13% to $34.15 after the company reported worse-than-expected Q1 adjusted EPS and sales results. The company also removed FY23 outlook in light of uncertain macroeconomic conditions.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) shares fell 12.6% to $10.08 after the company posted a net loss for the fourth quarter and said revenue could drop by as much as 10% for the current quarter.</li>
<li>Hillstream BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hils#NASDAQ">HILS</a>) shares fell 12.5% to $1.05. Hillstream BioPharma shares jumped over 78% on Tuesday after the company announced signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein..</li>
<li>Electronic Arts Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ea#NASDAQ">EA</a>) shares fell 12% to $113.29 after the company posted Q3 results and issued weak forecast.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) dipped 10.6% to $19.86.</li>
<li>Nuvve Holding Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvve#NASDAQ">NVVE</a>) dropped 8.8% to $1.25. Nuvve filed for a common stock offering of up to $25 million.</li>
<li>Cue Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hlth#NASDAQ">HLTH</a>) fell 8.2% to $2.4050</li>
<li>Match Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtch#NASDAQ">MTCH</a>) fell 7.7% to $49.98 after the company reported worse-than-expected financial results for its fourth quarter and issued weak guidance.</li>
<li>Western Digital Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wdc#NASDAQ">WDC</a>) dropped 3.3% to $42.50 after the company reported mixed fiscal second-quarter results and issued weak guidance.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/01/30624201/1m-bet-on-golden-entertainment-check-out-these-3-stocks-insiders-are-buying"> $1M Bet On Golden Entertainment? Check Out These 3 Stocks Insiders Are Buying</a>

BGXX

BIDU

CEMI

EBET

EDBL

ERYP

EVLO

GAME

GMVD

HILS

HLTH

IVDA

JANX

LPSN

MGAM

MRCY

MRIN

MSGM

MTCH

MVIS

NVVE

PTON

QNRX

RCRT

RNAZ

SBET

SNAP

SOBR

TSHA

VREX

Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Motorsport Games Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msgm#NASDAQ">MSGM</a>) shares rose 121% to $47.48 in pre-market trading after jumping over 710% on Tuesday. The company announced a debt-for-equity exchange with Motorsport Network. Also, Investor Mike Zoi reported purchase of 338,983 shares of Motorsport Games at an average price of $2.95 per share in Form 4 Filing.</li>
<li>Quoin Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) shares rose 67% to $2.77 in pre-market trading after gaining around 10% on Tuesday.</li>
<li>TransCode Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnaz#NASDAQ">RNAZ</a>) rose 42.5% to $1.07 in pre-market trading after the company reported preclinical results with immunotherapy candidate TTX-RIGA in melanoma.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) shares rose 39.2% to $1.10 in pre-market trading after gaining around 20% on Tuesday.</li>
<li>Genetic Technologies Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gene#NASDAQ">GENE</a>) rose 35.2% to $1.23 in pre-market trading. Genetic Technologies is forming strategic alliance with Qiagen, Reuters reported.</li>
<li>Lionheart III Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lion#NASDAQ">LION</a>) rose 30.2% to $13.50 in pre-market trading after dropping over 10% on Tuesday.</li>
<li>Marin Software Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrin#NASDAQ">MRIN</a>) rose 25.6% to $1.52 in pre-market trading after the company disclosed a new integration with Yahoo to enable enhanced campaign buying and optimization for advertisers.</li>
<li>Chembio Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cemi#NASDAQ">CEMI</a>) rose 23.3% to $0.4402 in pre-market trading. Biosynex and Chembio Diagnostics reported a definitive acquisition agreement.</li>
<li>Mobile Global Esports Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgam#NASDAQ">MGAM</a>) rose 21.7% to $3.14 in pre-market trading after jumping 158% on Tuesday. Mobile Global Esports said Nicholas (Nick) Venezia has joined MOGO as Chief Data Officer.</li>
<li>TMC The Metals Company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) rose 16.3% to $1.02 in pre-market trading. TMC The Metals Company recently filed prospectus for offering of up to $30 million common shares.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Taysha Gene Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsha#NASDAQ">TSHA</a>) fell 20.7% to $1.30 in pre-market trading after the company issued an update on TSHA-120 program in giant axonal neuropathy and a 2023 corporate outlook.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) shares fell 14.6% to $9.87 in pre-market trading after the company posted a net loss for the fourth quarter and said revenue could drop by as much as 10% for the current quarter.</li>
<li>AnPac Bio-Medical Science Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anpc#NASDAQ">ANPC</a>) shares dropped 14.4% to $7.27 in pre-market trading. AnPac Bio-Medical Science announced signing of $5.2 million of definitive investment agreements.</li>
<li>SOBR Safe, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sobr#NASDAQ">SOBR</a>) fell 14.4% to $1.54 in pre-market trading. SOBR Safe shares jumped 62% on Tuesday after the company announced that its first two SOBRcheck installations in the oil and gas industry were successful, driving expansion across all US locations for TerraTech Services.</li>
<li>SharpLink Gaming Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbet#NASDAQ">SBET</a>) fell 12.5% to $0.4715 in pre-market trading after surging 50% on Tuesday.</li>
<li>Hillstream BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hils#NASDAQ">HILS</a>) shares fell 12.1% to $1.05 in pre-market trading. Hillstream BioPharma shares jumped over 78% on Tuesday after the company announced signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein..</li>
<li>Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) fell 11.4% to $0.4604 in pre-market after gaining more than 24% on Tuesday. Blue Star Foods entered into supply agreement with Just Food For Dogs for up to $4 million annually.</li>
<li>G Medical Innovations Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmvd#NASDAQ">GMVD</a>) fell 10.1% to $4.49 in pre-market trading after declining around 8% on Tuesday. G Medical Innovations recently announced it received notice of patent issuance from the United States Patent and Trademark Office (USPTO) for vital signs sensors.</li>
<li>Context Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cntx#NASDAQ">CNTX</a>) fell 9.5% to $0.9587 in pre-market trading. Context Therapeutics shares jumped 55% on Tuesday after the company announced its clinical trial collaborator, Stemline Therapeutics, received approval from the FDA for ORSERDU in ER+, HER2-, ESR1-mutated breast cancer..</li>
<li>Match Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtch#NASDAQ">MTCH</a>) fell 8.7% to $49.40 in pre-market trading after the company reported worse-than-expected financial results for its fourth quarter and issued weak guidance.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/02/30661307/investor-optimism-improves-ahead-of-feds-decision"> Investor Optimism Improves Ahead Of Fed&#39;s Decision</a>

ANPC

CNTX

GENE

WLDS

Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket

Security Matters Limited ("SMX") (ASX:SMX), a publicly traded company on the Australian Securities Exchange, and Lionheart III Corp ("Lionheart") (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lion#NASDAQ">LION</a>), a publicly traded special purpose acquisition company, today announced that they have entered into a business combination agreement ("BCA") and accompanying scheme implementation deed ("SID") pursuant to which SMX will list on NASDAQ via a newly-formed Irish company ("SMX Ireland") ("Transaction") to be named "SMX Public Limited Company."
Upon the closing of the Transaction, the ordinary shares and warrants of SMX Ireland are expected to trade on NASDAQ under the new ticker symbols "SMX" and "SMXW", respectively, and SMX shall cease to be quoted on the ASX.
Key Figures: 
• Total proforma equity value of the combined group is expected to be $US360 million1 
• This reflects an implied pre-money valuation of SMX of US$200 million 
• SMX shareholders will receive consideration (the "Consideration") via a scheme of arrangement consisting of an aggregate of 20,000,000 ordinary shares of SMX Ireland ("SMX Ireland Shares") being 10.2432 SMX Shares per one (1) share in SMX Ireland, with an issued value of $10.00 per SMX Ireland Share 
• The parties expect a post-Transaction cash balance2 of $116 million (US) after fees and expenses (subject to Lionheart's public stockholders right to redeem their shares)3 
• At the closing, SMX shareholders will own approximately 55.5% of the combined company, if there are no redemptions by Lionheart's public stockholders 1The estimated US$360 million is comprised of the following: 
• US$200 million value for SMX 
• US$126 million of cash in trust with the SPAC if no redemptions 
• US$31 million SPAC sponsor position 
2 Post-Transaction Cash balance 
Approximately US$116 million assuming no redemptions 
Transaction expenses of approximately US$11 million 
3 We note recent SPAC transactions have been characterised by high redemption rates. 
911430509.2 
SMX – ‘Giving materials a memory of their origination and history, so they can be recycled, reused, and authenticated multiple times' 
The world is demanding greater and greater transparency, efficiency, and resilience. An ultimatum to do things better. A challenge loaded with exciting possibilities.
SMX is a company for the 21st century, enabling a transition to a circular economy that is positive, productive, and profitable for participants in the value chain – and for the planet. To unlock the way global businesses will operate tomorrow, SMX is an enabler for a real-world circular economy. 
Through SMX's white label B2B offerings, the future of a sustainable world is able to be created by narratives that connect tangible, sustainable, ESG practices with the brand's transparent traceability strategy, designed to create a profitable lifetime relationship with its customers that is circular rather than linear or transactional.
SMX – ‘The system within' 
SMX creates a sustainable system within the current supply chain, designed for the 21st century economy. The innovative SMX system empowers businesses to build the real-world circular economy our planet needs now. It will help change the way we operate from the inside out, to transform businesses into sustainable ecosystems that can work as a united whole.
SMX four key benefits 
• Enhanced data flow and circularity: The SMX proprietary and patented marker and block chain open system is able to store data at a molecular level within products and materials, allowing for increased transparency of marked content, for greater granularity and ease of recycling 
• Exciting knowledge gathering potential: The SMX reader is designed to enable easy data gathering at any point within the supply chain, without affecting the product or material, eliminate blind spots, and provide the complete picture 
• Multiple-stages and multiple-loops traceability: The resilience of the SMX marker and blockchain platform is designed to ensure that the data is never compromised or lost, enabling more accurate and reliable traceability as the material is recycled/reused multiple times 
• Multiple application possibilities: Each SMX marker is unique and can be applied to materials, providing access to a large number of markers and a system with greater potential for different applications
Transaction Overview 
The Transaction values SMX at US$200 million. The Transaction is anticipated to generate proceeds of up to approximately $116 million (US) cash, assuming no redemptions by Lionheart's public stockholders. These funds will be used to fund operations and strategic growth opportunities.
Under the BCA, a subsidiary of SMX Ireland will merge with and into Lionheart, with Lionheart surviving the merger as a wholly owned subsidiary of SMX Ireland, and existing Lionheart stockholders receiving SMX Ireland Shares and warrants in exchange for their existing Lionheart shares and warrants. 
911430509.2 
Under the SID, SMX has agreed to propose a scheme of arrangement under Part 5.1 of the Corporations Act ("Scheme") and capital reduction ("Capital Reduction") which, if implemented, will result in all shares in SMX being cancelled in return for SMX Ireland Shares, with SMX then issuing a share to SMX Ireland (resulting in SMX becoming a wholly owned subsidiary of SMX Ireland), subject to the satisfaction of various conditions, including: 
• Receipt of required regulatory approvals; 
• the approval of shareholders of both SMX and Lionheart; 
• no material adverse effect, prescribed events or breaches of representations and warranties; and 
• interdependence of the SID and BCA completing successfully; and other customary conditions to a scheme of arrangement, such as Australian court approval and an independent expert confirming that the transaction is in the best interests of SMX shareholders. 
All options on issue in the SMX Employee Share Option Plan ("ESOP") will be cancelled by private agreement and the holders of the ESOP options will be issued equivalent options in SMX Ireland. 
In addition, SMX has agreed to have non-ESOP options in SMX cancelled by private agreement or if necessary implement an option scheme under Part 5.1 of the Corporations Act ("Option Scheme") which, if implemented, will result in the SMX options held by participants in the Option Scheme being cancelled, and such participants receiving SMX Ireland Shares on the basis of a Black-Scholes valuation for each tranche, subject to SMX option holder approval, court approval and the satisfaction of various conditions.
The SID contains customary exclusivity provisions in favour of both parties including ‘no-shop' and ‘no-talk' restrictions, ‘no due diligence', a notification obligation, and matching right. A break fee of US$2 million is payable by SMX to Lionheart and vice versa in certain circumstances including, where directors withdraw their 
recommendations, where a party engages in a competing acquisition and where a party breaches the SID. 
Unanimous recommendation of the Directors The board of directors of Lionheart has unanimously approved the Transaction. The board of directors of SMX considers the Transaction to be in the best interest of SMX shareholders and option holders and unanimously recommends that SMX shareholders vote in favour of the Scheme and Capital Reduction and SMX option holders vote in favour of the Option Scheme, in the absence of a superior proposal and subject to an independent expert concluding in the independent expert's report (and continuing to conclude) that the Scheme is in the best interests of SMX shareholders and option holders. 
Subject to those same qualifications, each member of the SMX board of directors intends to vote all of its SMX shares and/or options held or controlled by them in favour of the Scheme, the Capital Reduction and the Option Scheme.
Haggai Alon will be appointed as CEO of SMX Ireland, the parent of the SMX Group and its subsidiaries. He will receive a market based CEO salary. 
911430509.2 
Indicative Timetable and next steps 
SMX shareholders do not need to take any action at this stage.
A Scheme Booklet containing information in relation to the Transaction, reasons for the SMX Directors' recommendation, an Independent Expert's Report and details of the Scheme will be sent to SMX shareholders in due course. It is anticipated that the Transaction will close in the early 4th quarter of 2022, subject to, among other things, the approval of both Lionheart's and SMX's shareholders (including option holders), the approval of the Court and satisfaction or waiver of a number of conditions. These dates are indicative and subject to change. 
Other information 
Additional information about the proposed Transaction will be provided in a Current Report on Form 8-K to be filed by Lionheart with the U.S. Securities and Exchange Commission and available at <a href="http://www.sec.gov" title="www.sec.gov">www.sec.gov</a>, and a scheme booklet to be prepared by SMX for consideration by SMX shareholders and option holders in due course.
SMX Ireland, will be led by Haggai Alon as CEO and Ophir Sternberg as Chairman of the Board. The Advisory Board will be comprised of Yair Seroussi, Major General Ami Shafran and Yigal Unna. 
Advisors 
ClearThink Capital is serving as financial advisor to SMX. EF Hutton, a division of Benchmark Investments, LLC, is serving as financial advisor to Lionheart III Corp. K&amp;L Gates, Afik &amp; Co Attorneys &amp; Notary and Arthur Cox LLP are serving as legal counsel to SMX. DLA Piper is serving as legal counsel to Lionheart III Corp. Futerra will act as SMX's global brand strategy agency

Security Matters Limited to Become Publicly Traded on Nasdaq Through Merger With Lionheart III Corp

Morgan Stanley lowered the firm's price target on Lionsgate (LGF.A) Studios (LION) to $8 from $9 and keeps an Overweight rating on the shares. The ...

Lionsgate Studios price target lowered to $8 from $9 at Morgan Stanley

Morgan Stanley analyst Thomas Yeh lowered the firm's price target on Lionsgate (LGF.A) Entertainment (LGF.B) to $9 from $10 and keeps an Overweight...

Lionsgate price target lowered to $9 from $10 at Morgan Stanley

Morgan Stanley analyst Thomas Yeh maintained a Buy rating on Lionsgate Studios (LION – Research Report) today and set a price target of $8.00. The ...

Morgan Stanley Sticks to Its Buy Rating for Lionsgate Studios (LION)

Lionsgate Studios Corp. ( ($LION) ) has released its Q2 earnings. Here is a breakdown of the information Lionsgate Studios Corp. presented to its i...

Lionsgate Studios Post Challenging Q2 Earnings

Seaport Research analyst David Joyce lowered the firm's price target on Lionsgate Studios (LION) to $10 from $12 and keeps a Buy rating on the shar...

Lionsgate Studios price target lowered to $10 from $12 at Seaport Research

"Venom: The Last Dance" tops weekend movie box office for the third straight week

Lionsgate Studios (LION) and Kingdom Story Company announced that the companies have agreed to renew their three-year first-look deal, extending th...

Lionsgate, Kingdom Story Company renew three-year first-look deal

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Lionsgate Studios (NASDAQ:<a href="https://investorplace.com/stock-quotes/lion-stock-quote/">LION</a>) just reported results for the first quarter of 2025.<ul><li>Lionsgate Studios reported earnings per share of 9 cents.</li><li>The company reported revenue of $834.70 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	
	The post <a href="https://investorplace.com/earning-results/2024/08/lion-stock-earnings-lionsgate-studios-for-q1-of-2025/">LION Stock Earnings: Lionsgate Studios Reported Results for Q1 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

LION Stock Earnings: Lionsgate Studios Reported Results for Q1 2025

'Red One' earns $34.1M in opening weekend against budget of at least $200M

Comments

Lionsgate Studios

Lionsgate Studios (LION) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga